(Q28194261)

12 December 2020

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

1 reference

12 December 2020

Accuracy of stool antigen test in posteradication assessment of Helicobacter pylori infection

1 reference

12 December 2020

Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study

1 reference

12 December 2020

Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

1 reference

12 December 2020

Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori

1 reference

12 December 2020

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

1 reference

12 December 2020

Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies

1 reference

12 December 2020

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

1 reference

12 December 2020

The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia

1 reference

12 December 2020

Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline

1 reference

12 December 2020

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

1 reference

12 December 2020

Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils

1 reference

12 December 2020

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

12 December 2020

Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease

1 reference

12 December 2020

Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up

1 reference

12 December 2020

Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials

1 reference

12 December 2020

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

1 reference

12 December 2020

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

12 December 2020

Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection.

1 reference

12 December 2020

Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

1 reference

12 December 2020

Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia

1 reference

12 December 2020

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

1 reference

12 December 2020

The stool antigen test for detection of Helicobacter pylori after eradication therapy

1 reference

12 December 2020

Helicobacter pylori infection and the development of gastric cancer

1 reference

12 December 2020

Human plasma is directly bacteriocidal against Helicobacter pylori in vitro, potentially explaining the decreased detection of Helicobacter pylori during acute upper GI bleeding

1 reference

12 December 2020